DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

EHA 2018: Shifting Paradigms in NHL

View more

ASCO Highlights and Industry Implications

View more

Avastin’s FDA Approval in First-line Ovarian Cancer

View more
Ask us your question

Collaboration is Key to Accelerating Diagnostics Access to Precision Medicines

View more
Ask us your question

Merck Set to Consolidate its Dominant Position in First-line Metastatic NSCLC

View more

Metastatic Castrate Resistant Prostate Cancer Global Forecast

View more

Oncology Team Extends Presence in Treatment Pathway with Epi and Claims Analysis

View more

Difficulties Developing Combinations with Immune Checkpoint Inhibitors

View more

Immune Checkpoint Inhibitors - Late-Phase Trials Poised to Disrupt the Market

View more